Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eichelbaum

Showing results (111-120 of 263) with videos related to

Pageof 27
Sort By:
Arzneimittel-Forschung|January 1, 1982
Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administrationM Eichelbaum, H R Ochs, G Roberts, et al.
Biochemical Pharmacology|December 1, 1987
Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation. Characterization of bufuralol 1'-hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetic deficiencyP Dayer, T Kronbach, M Eichelbaum, et al.
Experimental and Molecular Pathology|December 1, 1971
3-Methylcholanthrene blocks hepatic necrosis induced by administration of bromobenzene or carbon tetrachlorideW D Reid, B Christie, M Eichelbaum, et al.
British Journal of Clinical Pharmacology|November 1, 1987
Application of stable isotope methodology to study the pharmacokinetics, bioavailability and metabolism of nitrendipine after i.v. and p.o. administrationG Mikus, C Fischer, B Heuer, et al.
Therapeutic Drug Monitoring|January 1, 1984
Carbamazepine levels in breast milkW Froescher, M Eichelbaum, M Niesen, et al.
Hepatology (Baltimore, Md.)|October 1, 1996
Differential induction of prehepatic and hepatic metabolism of verapamil by rifampinM F Fromm, D Busse, H K Kroemer, et al.
Molecular Pharmacology|July 1, 1991
Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanismH K Kroemer, C Fischer, C O Meese, et al.
Klinische Wochenschrift|September 15, 1980
Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single I.V. and oral administration and during chronic treatmentM Eichelbaum, P Birkel, E Grube, et al.
British Journal of Clinical Pharmacology|November 1, 1980
Influence of meso-caval shunt surgery on verapamil kinetics, bioavailability and responseM Eichelbaum, M Albrecht, G Kliems, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Influence of sequential exposure to R-verapamil or B8509-035 on rhodamine 123 accumulation in human lymphoblastoid cell linesE Roller, B Klumpp, J Krause, et al.
Pageof 27

Showing results (111-120 of 263) with videos related to

Sort By:
Pageof 27
Arzneimittel-Forschung|January 1, 1982
Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administrationM Eichelbaum, H R Ochs, G Roberts, et al.
Biochemical Pharmacology|December 1, 1987
Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation. Characterization of bufuralol 1'-hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetic deficiencyP Dayer, T Kronbach, M Eichelbaum, et al.
Experimental and Molecular Pathology|December 1, 1971
3-Methylcholanthrene blocks hepatic necrosis induced by administration of bromobenzene or carbon tetrachlorideW D Reid, B Christie, M Eichelbaum, et al.
British Journal of Clinical Pharmacology|November 1, 1987
Application of stable isotope methodology to study the pharmacokinetics, bioavailability and metabolism of nitrendipine after i.v. and p.o. administrationG Mikus, C Fischer, B Heuer, et al.
Therapeutic Drug Monitoring|January 1, 1984
Carbamazepine levels in breast milkW Froescher, M Eichelbaum, M Niesen, et al.
Hepatology (Baltimore, Md.)|October 1, 1996
Differential induction of prehepatic and hepatic metabolism of verapamil by rifampinM F Fromm, D Busse, H K Kroemer, et al.
Molecular Pharmacology|July 1, 1991
Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanismH K Kroemer, C Fischer, C O Meese, et al.
Klinische Wochenschrift|September 15, 1980
Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single I.V. and oral administration and during chronic treatmentM Eichelbaum, P Birkel, E Grube, et al.
British Journal of Clinical Pharmacology|November 1, 1980
Influence of meso-caval shunt surgery on verapamil kinetics, bioavailability and responseM Eichelbaum, M Albrecht, G Kliems, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Influence of sequential exposure to R-verapamil or B8509-035 on rhodamine 123 accumulation in human lymphoblastoid cell linesE Roller, B Klumpp, J Krause, et al.
Pageof 27